We hypothesised that Pad4 deficiency would ameliorate obesity-related metabolic and behavioural complications in both sexes, as evidenced by studies using HFD, which showed no sex differences in body weight gain. The gene discussed is PADI4; the disease is obesity due to melanocortin 4 receptor deficiency.